期刊文献+

固有免疫应答在系统性硬皮病发病机制中的研究进展 被引量:4

The recent progress of innate immunity in the pathogenesis of systemic sclerosis
下载PDF
导出
摘要 系统性硬皮病(systemic sclerosis,SSc)是以皮肤及各内脏器官慢性纤维化为特征的自身免疫病。SSc发病中,固有免疫应答在激活免疫系统和纤维化过程中均发挥重要作用。固有免疫系统一方面通过抗原提呈作用,建立与适应性免疫应答的桥梁;另一方面通过分泌和调节关键的细胞因子促进炎症反应和组织纤维化过程。本文针对固有免疫系统中关键的单核/巨噬细胞、肥大细胞、中性粒细胞和树突状细胞等细胞成分,以及近年来重点关注的Toll样受体及其配体和IL-4、IL-6、TGF-β等细胞因子进行综述,旨在阐明固有免疫应答在SSc发病中的作用,以助于本病的临床评估及靶向分子治疗。 Systemic sclerosis(SSc)is an autoimmune disease characterized by progressive fibrosis of the skin and various internal organs.The innate immunity is crucial in the activation of inflammatory response and onset of fibrosis in the pathogenesis of SSc.On one hand,the innate immune system regulates the activation of adaptive immune system through antigen presentation,and on the other hand,it promotes local inflammation and matrix accumulation via production of various proinflammatory cytokines.This review aims at the important role of monocytes/macrophages,mast cells,neutrophils and dendritic cells in innate immune system,as well as Toll-like receptors and their ligands and proinflammatory cytokines(including IL-4,IL-6 and TGF-β)in SSc.The elaboration of innate immunity in the pathogenesis of SSc will contribute to the clinical implications and the therapeutic targeting of effector molecules.
作者 王芳 张建中 杜娟 WANG Fang;ZHANG Jianzhong;DU Juan(Peking University People's Hospital,Beijing 100044,China)
出处 《中国麻风皮肤病杂志》 2021年第7期466-470,共5页 China Journal of Leprosy and Skin Diseases
基金 北京市自然科学基金(编号:7214262)。
关键词 系统性硬皮病 固有免疫 TOLL样受体 单核/巨噬细胞 肥大细胞 白介素-4 转化生长因子-Β systemic sclerosis innate immunity monocyte/macrophages mast cells toll-like receptors Interleukin-4 transforming growth factor-β
  • 相关文献

参考文献1

二级参考文献22

  • 1De Palma R, Del Galdo F, Lupoli S, et al. Peripheral T lymphocytes from patients with early systemic sclerosis co - cultured with autologous fibroblasts undergo an oligoclonal expansion similar to that occurring in the skin. Clin Exp Immunol 2006; 144:169 - 176.
  • 2Tiev KP, Abriol J, Burland MC, et al. T cell repertoire in patients with stable scleroderma. Clin Exp Immunol 2005; 139(2) :348 - 354.
  • 3Sakkas LI, Xu B, Arflett CM, et al. Oligoclonal T cell expansion in the skin of patients with systemic sclerosis. J Immunol 2002; 168: 3649- 3659.
  • 4Kalogerou A, Gelou E, Mountantonakis S, et al. Early T cell activation in the skin from patients with systemic sclerosis. Ann Rheum Dis 2006;64:1233 - 1235.
  • 5Chizzolini C, Parel Y, De Luca C, et al. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane - associated tumor necrosis factor alpha. Arthritis Rheum 2003;48:2593 - 2604.
  • 6Boin F, Wigley FM, Schneck JP, et al. Evaluation of topoisomerase - 1 - specific CD8^+ T- cell response in systemic sclerosis. Ann NY Acad Sci 2005; 1062:137 - 145.
  • 7Lambert NC, Pang JM, Yan Z, et al. Male microchimerism in women with systemic sclerosis and healthy women who have never given birth to a son. Ann Rheum Dis 2005;64(6) :845 - 848.
  • 8Kuwana M, Okano Y, Pandey JP, et al. Enzyme- linked immunosorbent assay for detection of anti- RNA polymerase Ⅲ antibody: analytical accuracy and clinical associations in systemic sclerosis. Evaluation Studies. Arthritis Rheum 2005;52(8) :2425 - 2432.
  • 9Overzet K, Gensler TJ, Kim SJ, et al. Small nucleolar RNP scleroderma autoantigens associate with phosphorylated serine/argininesplicing factors during apoptosis. Arthritis Rheum 2000;43: 1327- 1336.
  • 10La Placa M, Bianchi T, Vitone F, et al. Serum antibody reactivity to human intracisternal A- type particle retrovirus proteins in systemic sclerosis patients. Acta Derm Venereol 2004;84(3): 177 - 180.

同被引文献33

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部